Transchem allots 6.15 crore warrants at ₹75 each

2 min read     Updated on 03 Jun 2026, 05:42 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Transchem Limited's Preferential Issue Committee approved the allotment of 6.15 crore warrants at ₹75 each on June 03, 2026. The company received ₹115.31 crore as an upfront payment from four non-promoter investors, including Bakkt Opco Holdings. The warrants are convertible into equity shares within 18 months, potentially raising a total of ₹461.25 crore.

powered bylight_fuzz_icon
42034308

*this image is generated using AI for illustrative purposes only.

Transchem Limited has allotted 6,15,00,000 warrants on a preferential basis at an issue price of ₹75 per warrant to four non-promoter investors. The Preferential Issue Committee approved the allotment on June 03, 2026, following an in-principle approval from BSE Limited. The company received ₹115,31,25,000 as upfront payment, representing 25% of the warrant issue price, with the balance payable upon conversion into equity shares.

The warrants carry a right to subscribe to one fully paid-up equity share with a face value of ₹10 each. This right can be exercised during the period commencing from the date of allotment until the expiry of 18 months. The total issue size aggregates to ₹461,25,00,000, assuming full conversion of the warrants. There is no immediate change in the paid-up equity share capital of the company due to this allotment.

Allotment Details

The allotment was made to Bakkt Opco Holdings, LLC, Mr. Pishu V Chainani, JVS Holdings LLP, and Mr. Dhawal Jiwankumar Mehta. The table below details the number of warrants allotted and the subscription amount received from each investor.

Sr. No. Name No. of Warrants allotted Warrant Issue Price (₹) Amount Received (₹)
1 Bakkt Opco Holdings, LLC 4,75,00,000 75.00 89,06,25,000
2 Mr. Pishu V Chainani 1,20,00,000 75.00 22,50,00,000
3 JVS Holdings LLP 16,00,000 75.00 3,00,00,000
4 Mr. Dhawal Jiwankumar Mehta 4,00,000 75.00 75,00,000
TOTAL TOTAL 6,15,00,000 115,31,25,000

Shareholding Pattern

Upon full exercise of the warrants, the allottees will hold a significant portion of the company's equity. Bakkt Opco Holdings, LLC is set to become the largest shareholder with a 64.42% stake, followed by Mr. Pishu V Chainani with 16.27%. The total post-preferential allotment shareholding for these investors will reach 83.40%.

Name of Allottee Pre-allotment Shares Post-allotment Shares Post-allotment %
Bakkt Opco Holdings, LLC Nil 4,75,00,000 64.42%
Mr. Pishu V Chainani Nil 1,20,00,000 16.27%
JVS Holdings LLP Nil 16,00,000 2.17%
Mr. Dhawal Jiwankumar Mehta Nil 4,00,000 0.54%
Total Nil 6,15,00,000 83.40%

The issuance was conducted in accordance with Chapter V of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, and the applicable provisions of the Companies Act, 2013.

Historical Stock Returns for Transchem

1 Day5 Days1 Month6 Months1 Year5 Years
+4.99%+33.97%+70.18%+145.83%+618.34%+953.04%

What strategic partnerships or business expansions does Transchem Limited plan to pursue with the ₹461.25 crore capital infusion?

How will the entry of Bakkt Opco Holdings as the majority shareholder influence Transchem's future operational direction and management structure?

What is the likelihood of full warrant conversion given the 18-month timeframe, and what factors could deter investors from exercising their rights?

Transchem gets BSE nod for preferential warrant issue

1 min read     Updated on 22 May 2026, 11:47 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Transchem Limited received in-principle approval from BSE to issue 6,15,00,000 warrants of Rs. 10 each, following an intimation dated November 21, 2025. The company has designated an estimated ₹115 crore for General Corporate Purposes, with funds to be utilized over 6-18 months, while other proceeds will target strategic acquisitions in the broking sector. Allottee details include Bakkt Opco Holdings, LLC, controlled by NYSE-listed Bakkt, Inc.

powered bylight_fuzz_icon
40896842

*this image is generated using AI for illustrative purposes only.

Transchem Limited has received in-principle approval from BSE Limited for the preferential issue of 6,15,00,000 warrants of Rs. 10 each. The approval, granted via a letter dated May 21, 2026, was communicated to the stock exchanges on May 22, 2026. With the necessary regulatory approvals secured, the company will now initiate steps to consummate the preferential issue.

Utilization of Proceeds

The company has previously disclosed that an estimated amount of ₹115 crore from the issue proceeds has been designated for General Corporate Purposes (GCP). This allocation is intended to meet the general corporate needs of the company while ensuring compliance with the SEBI ICDR Regulations. The indicative timeline for the utilization of these funds is set between 6 to 18 months.

Sr.No. Particulars Estimated Amount (Rs. Cr) Indicative Timeline
5 General Corporate Purposes (“GCP”) - For meeting general corporate purposes of the Company, with such utilisation towards general corporate purposes being in compliance with the SEBI ICDR Regulations and not exceeding the limits prescribed thereunder 115 6-18 months

Strategic Acquisitions

Proceeds related to Sr. No. 1 of the objects are proposed to be utilised for strategic acquisitions, directed solely towards the broking and allied financial services sector. Transchem stated that the target entities intended for these investments or acquisitions are expected to become subsidiaries of the company under Section 2(87) of the Companies Act, 2013, subject to the completion of transactions and necessary approvals.

Shareholder and Allottee Details

Regarding the allottees, the disclosure clarified that Bakkt Opco Holdings, LLC (Allottee 1) is owned and controlled by Bakkt, Inc., a company listed on the New York Stock Exchange (NYSE: BKKT). Consequently, the company noted that it is not necessary to identify and verify the identity of any shareholder or beneficial owner of this allottee as per the SEBI Circular CIR/MIRSD/2/2013 dated January 24, 2013.

Historical Stock Returns for Transchem

1 Day5 Days1 Month6 Months1 Year5 Years
+4.99%+33.97%+70.18%+145.83%+618.34%+953.04%

Which specific broking and allied financial services companies is Transchem Limited targeting for strategic acquisitions using the preferential issue proceeds?

How will Bakkt, Inc.'s involvement as a key allottee influence Transchem's strategic direction toward digital assets and cryptocurrency-related financial services in India?

What impact will the significant equity dilution from 6.15 crore new warrants have on existing shareholders' ownership percentage and the company's stock valuation?

More News on Transchem

1 Year Returns:+618.34%